Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children’s Oncology Group

שנת פרסום ראשונה: יולי 2012
שנת עדכון:
מפרסם: Journal of Clinical Oncology

The difference in EFS between the regimens did not reach significance on the basis of the stratified log-rank test. The 5-year EFS was higher for TPCV on the basis of the cure model analysis. Differences in toxicity may influence physician choice of regimens.

Joann L. AterTianni ZhouEmiko HolmesClaire M. MazewskiTimothy N. BoothDavid R. FreyerKen H. LazarusRoger J. PackerMichael PradosRichard SpostoGilbert VezinaJeffrey H. Wisoff, and Ian F. Pollack

Journal of Clinical Oncology 2012 30:212641-2647 

http://ascopubs.org/doi/10.1200/JCO.2011.36.6054